Summary & Overview
HCPCS Q4439: Instagraft per Square Centimeter (Add-on)
HCPCS Level II code Q4439 designates Instagraft billed per square centimeter as an add-on product used alongside primary procedures for grafting and advanced wound management. Nationally, biologic graft products are important in reconstructive surgery and complex wound care due to their role in promoting tissue repair and reducing the need for repeat procedures. Clear coding for add-on graft materials affects billing accuracy, payer coverage decisions, and clinical documentation workflows.
Key payers in this review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines which payers commonly cover biologic graft products, how coverage policies typically treat add-on graft materials, and common documentation expectations required for reimbursement.
Readers will learn the clinical context for Q4439, typical sites of service where Instagraft is used, and practical billing considerations such as its add-on designation and per-square-centimeter reporting. The report also summarizes benchmarks for utilization and reimbursement patterns, highlights relevant policy updates from major payers and Medicare, and identifies documentation elements that influence coverage decisions. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code Q4439 describes Instagraft, billed per square centimeter. This is an add-on product intended to be listed separately in addition to a primary procedure when used to augment soft tissue grafting or wound repair.
Service type: Biologic graft product / wound management adjunct
Typical site of service: Inpatient and outpatient surgical settings, wound care clinics, and procedure suites where grafting or advanced wound management is performed.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a full-thickness or deep partial-thickness skin deficit from trauma, chronic nonhealing wound, or post-excisional defect requiring a dermal regenerative matrix application. In a dermatologic or reconstructive plastic surgery clinic, the patient presents for operative management after wound bed preparation and debridement. The surgical team measures the defect in square centimeters and orders Q4439 (Instagraft, per square centimeter) as an add-on material to be applied over the prepared wound. The workflow includes preoperative assessment, wound debridement and hemostasis, sizing and trimming of the Instagraft graft to cover the defect, placement and fixation of the graft to the wound bed, and appropriate dressing and postoperative instructions. Typical follow-up visits occur within 48–72 hours for dressing check and at 1–2 weeks for graft take assessment, with additional visits as clinically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
RT | Right side | Use when the graft application is to a lesion or wound on the right side of the body where laterality reporting is required. |
LT | Left side | Use when the graft application is to a lesion or wound on the left side of the body where laterality reporting is required.